TIA
RMTI icon

Traphagen Investment Advisors’s Rockwell Medical RMTI Stock Holding History

Traphagen Investment Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,110
Closed -$19.5K – 185
2024
Q2 		$19.5K Hold
1,110
– – ﹤0.01% 172
2024
Q1 		$18.4K Hold
1,110
– – ﹤0.01% 174
2023
Q4 		$21K Buy
+1,110
New +$20.9K ﹤0.01% 171

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Traphagen Investment Advisors's RMTI Position: Q3 2024 in Review

Traphagen Investment Advisors sold out of Rockwell Medical (RMTI) in Q3 2024, closing a stake of 1,110 shares — an estimated $19.5K sold.

Traphagen Investment Advisors first reported a position in RMTI in Q4 2023 and held it in 3 quarters. The position peaked at $21K in Q4 2023. 53 funds tracked by Wall St. Rank hold RMTI as of Q3 2024.

  • Traphagen Investment Advisors reported no remaining Rockwell Medical position as of Q3 2024 after selling out during the quarter.
  • Traphagen Investment Advisors sold 1,110 Rockwell Medical shares in Q3 2024, an estimated $19.5K.
  • Traphagen Investment Advisors first reported a position in Rockwell Medical in Q4 2023 and held it in 3 quarters.
  • Traphagen Investment Advisors's Rockwell Medical position peaked at $21K in Q4 2023.
  • 53 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2024.

Based on Traphagen Investment Advisors's 13F filing for Q3 2024, filed 21 Oct 2024.